SCHEMBL31641997

SCHEMBL31641997

C[C@H](NC(=O)OC(C)(C)C)C(=O)N1CCN(c2cccc(OC(F)(F)F)c2)CC1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ PHGDH O43175 1/20 0.46
▸ ACACB O00763 1/20 0.46
▸ NOTUM Q6P988 1/20 0.45
▸ CHRM4 P08173 2/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ HRH2 P25021 2/20 0.44
▸ HRH1 P35367 2/20 0.44
▸ DHFR P00374 1/20 0.43
▸ CCKAR P32238 1/20 0.43
▸ LMNA P02545 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ SCN9A Q15858 1/20 0.41
▸ MLYCD O95822 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.41
▸ CASR P41180 2/20 0.41
▸ ENPP2 Q13822 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31642022 1.00 L3MBTL1 (0.50) L3MBTL1PHGDHACACBNOTUMCHRM4
SCHEMBL31639157 0.88 ACACB (0.55) L3MBTL1PHGDHACACBNOTUMCHRM4
SCHEMBL31638941 0.88 ACACB (0.55) L3MBTL1PHGDHACACBNOTUMCHRM4
SCHEMBL31641939 0.88 MC4R (0.45) L3MBTL1PHGDHACACBNOTUMCHRM4
SCHEMBL31642103 0.88 MC4R (0.45) L3MBTL1PHGDHACACBNOTUMCHRM4
SCHEMBL31642411 0.86 CHRM4 (0.43) L3MBTL1PHGDHACACBNOTUMCHRM4
SCHEMBL31641422 0.86 L3MBTL1 (0.66) L3MBTL1HSD17B10LMNASMN1; SMN2
SCHEMBL31642576 0.86 L3MBTL1 (0.66) L3MBTL1HSD17B10LMNASMN1; SMN2
SCHEMBL31642455 0.85 L3MBTL1 (0.50) L3MBTL1PHGDHACACBNOTUMCHRM4
SCHEMBL31642091 0.85 L3MBTL1 (0.50) L3MBTL1PHGDHACACBNOTUMCHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025136133-A1 PHENYLPIPERAZINAMIDE DERIVATIVES MODIFIED WITH ALIPHATIC AMINO ACID FRAGMENTS FOR THE TREATMENT OF NEUROLOGICAL DISEASES Uniwersytet Jagielloński (PL) 2025-06-26 — — WO disclosed
Send feedback